Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

21.90
Delayed Data
As of 4:00pm ET
 +0.10 / +0.46%
Today’s Change
13.60
Today|||52-Week Range
33.00
+16.49%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close21.80
Today’s open21.65
Day’s range21.40 - 22.13
Volume416,333
Average volume (3 months)813,695
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+528.00%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.50

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...-0.41-2.10%
DVAXDynavax Technologies...-0.20-1.22%
DERMDermira Inc-0.49-2.09%
OMEROmeros Corp-0.45-2.00%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.62
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts